Clostridium difficile laboratory testing in Australia and New Zealand: National survey results and Australasian society for infectious diseases recommendations for best practice

Pathology

Volumn 43, Issue 5, 2011, Pages 482-487

  Ferguson, John K ^a   Cheng, Allen C ^d   Gilbert, Gwendolyn L ^b   Gottlieb, Thomas ^c   Korman, Tony ^e   Mcgregor, Alistair ^g   Richards, Michael ^f   Roberts, Sally ^k   Robson, Jenny ^h   Van Gessel, Helen ⁱ   Riley, Thomas V ^j  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Department of Microbiology and Infectious Diseases   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e MONASH UNIVERSITY   (Australia)

^f ROYAL MELBOURNE HOSPITAL   (Australia)

^g ROYAL HOBART HOSPITAL   (Australia)

^h SULLIVAN NICOLAIDES PATHOLOGY   (Australia)

ⁱ DEPARTMENT OF HEALTH   (Australia)

^j UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^k AUCKLAND CITY HOSPITAL   (New Zealand)

more..

Author keywords

Australia; Clostridium difficile; Clostridium difficile testing recommendations; Epidemiology; New Zealand; Surveillance

Indexed keywords

EID: 80052127895     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e328348c9b4     Document Type: Article

References (25)

1. Riley TV. Nosocomial diarrhoea due to Clostridium difficile. Curr Opin Infect Dis 2004; 17: 323-7.
2. Barbut F, Decre D, Lalande V, et al. Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADPribosyltransferase)- producing strains. J Med Microbiol 2005; 54: 181-5.
3. Riley TV. Epidemic Clostridium difficile. Med J Aust 2006; 185: 133-4.
4. Riley TV, Thean S, Hool G, Golledge CL. First Australian isolation of epidemic Clostridium difficile PCR ribotype 027. Med J Aust 2009; 190: 706-8.
5. Richards MJ, Knox J, Elliott B. et al. Severe infection with Clostridium difficile PCR ribotype 027 acquired in Melbourne, Australia. Med J Aust 2011; 194: (in press).
6. New South Wales Health. Media release: Health Testing Finds New Bacteria Strain. http://www.health.nsw.gov.au/news/2010/20101217-01.html.
7. Cheknis AK, Sambol SP, Davidson DM, et al. Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007. Anaerobe 2009; 15: 230-3.
8. Roberts S, Heffernan H, Al Anbuky N, et al. Molecular epidemiology and susceptibility profiles of Clostridium difficile in New Zealand, 2009. N Z Med J 2011; 124: 1332.
9. VanGessel H. Measuring the incidence of Clostridium difficile-associated diarrhoea in a group of Western Australian hospitals. Healthcare Infect 2008; 13: 56-62.
10. National Clostridium Difficile Standards Group. Report to the UK Department of Health, February 2003. http://www.hpa.org.uk/web/HPAwebFile/ HPAweb-C/1194947372533
11. Kuijper EJ, Coignard B, Tüll P; ESCMID Study Group for Clostridium difficile; EU Member States; European Centre for Disease Prevention and Control. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006; 12 (Suppl 6): 2-18.
12. Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 2009; 15: 1053-66.
13. Van Den Berg RJ, Vaessen N, Endtz HP, Schulin T, Van Der Vorm ER, Kuijper EJ. Evaluation of real-time PCR and conventional diagnostic methods for the detection of Clostridium difficile-associated diarrhoea in a prospective multicentre study. J Med Microbiol 2007; 56: 36-42.
14. Riley TV, O'Neill GL, Bowman RA, Golledge CL. Clostridium difficileassociated diarrhoea: Epidemiological data from Western Australia. Epidemiol Infect 1994; 113: 13-20.
15. Riley TV, Cooper M, Bell B, Golledge CL. Community-acquired Clostridium difficile-associated diarrhea. Clin Infect Dis 1995; 20 (Suppl 2): S263-5.
16. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431-55.
17. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431-55.
18. Jaber MR, Olafsson S, Fung WL, Reeves ME. Clinical review of the management of fulminant Clostridium difficile infection. Am J Gastroenterol 2008; 103: 3195-203; quiz 204.
19. Kim J, Smathers SA, Prasad P, Leckerman KH, Coffin S, Zaoutis T. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics 2008; 122: 1266-70.
20. Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis 2010; 16: 604-9.
21. Nemat H, Khan R, Ashraf MS, et al. Diagnostic value of repeated enzyme immunoassays in Clostridium difficile infection. Am J Gastroenterol 2009; 104: 2035-41.
22. Drees M, Snydman DR, O'Sullivan CE. Repeated enzyme immunoassays have limited utility in diagnosing Clostridium difficile. Eur J Clin Microbiol Infect Dis 2008; 27: 397-9.
23. Cardona DM, Rand KH. Evaluation of repeat Clostridium difficile enzyme immunoassay testing. J Clin Microbiol 2008; 46: 3686-9.
24. Aichinger E, Schleck CD, Harmsen WS, Nyre LM, Patel R. Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J Clin Microbiol 2008; 46: 3795-7.
25. Arvand M, Hauri AM, Zaiss NH, Witte W, Bettge-Weller G. Clostridium difficile ribotypes 001, 017, and 027 are associated with lethal C. difficile infection in Hesse, Germany. Euro Surveill 2009; 14: 19403